0
0

Department of Health and Human Services Awarded a Contract to GENCYTE THERAPEUTICS INC for $499,990.00

Signed on

9/3/2025, 12:00 AM

GENCYTE THERAPEUTICS INC Government Contract #75N91025C00046

GENCYTE THERAPEUTICS INC was awarded a contract with the United States Government for $499,990.00. The contract was awarded by the agency office NIH NCI, which is a division with the National Institutes of Health within the Department of Health and Human Services.

Summary of Award

The federal contract was awarded to GENCYTE THERAPEUTICS INC, a small business in California. The contract is for a research and development project on a molecular adaptor system for JMML treatment, funded by the Department of Health and Human Services through the National Institutes of Health, with a total award amount of $499,990. The contract was competitively awarded after excluding some sources, with 16 offers received.

Contract Details

Contract ID75N91025C00046
Contract TypeD
Total Obligation$499,990.00
Exercised Options$499,990.00
Base Amount + Options$499,990.00
Date Signed2025-09-03
Contract DescriptionPHASE I SBIR CONCEPT AWARD FOR LOGIC GATED MOLECULAR ADAPTOR SYSTEM FOR JMML TREATMENT
Start Date2025-09-12
End Date2026-09-11

Agency Details

Awarding AgencyDepartment of Health and Human Services
Awarding Sub AgencyNational Institutes of Health
Awarding OfficeNIH NCI
Funding AgencyDepartment of Health and Human Services
Funding Sub AgencyNational Institutes of Health
Funding OfficeNIH NCI

Recipient Details

RecipientGENCYTE THERAPEUTICS INC
Recipient Location930 BRITTAN AVE SAN CARLOS CALIFORNIA, UNITED STATES
Business CategoriesAsian Pacific American Owned Business, Category Business, Corporate Entity Not Tax Exempt, Minority Owned Business, Self-Certified Small Disadvantaged Business, Small Business, Special Designations, U.S.-Owned Business

Comments

Award Transactions

Transaction #0$499,990.00September 3, 2025

National Institutes of Health, a sub agency of Department of Health and Human Services, issued a payment of $499,990.00 to GENCYTE THERAPEUTICS INC. The payment included a Subsidy Cost of $0.00.